double-skinned crabsVietnamese crab exporter
Advertisement
Science
ChinaPolitics

China bans clinical research in germline genome editing as ‘irresponsible’

  • New guideline marks China’s latest effort to tighten ethics oversight after He Jiankui shocked the world with first gene-edited babies

2-MIN READ2-MIN
1
Germline gene engineering relates to altering the DNA in sperm, eggs or early embryos to introduce heritable changes. Photo: Shutterstock
Alcott Wei
China has banned all clinical research involving germline genome editing under a newly released ethics guideline.

Germline gene engineering relates to altering the DNA in sperm, eggs or early embryos to introduce changes that can be inherited.

“Any clinical research involving germline genome editing is irresponsible and not permitted,” according to the Ethical Guideline for Human Genome Editing Research, released earlier this week by China’s Ministry of Science and Technology.

Select Voice
Select Speed
1x
AI-generated voice